Company news: Sanofi, Elsevier

Share this article:
J&J's McNeil Consumer Healthcare sold its Rolaids brand to Sanofi's Tennessee-based Chattem OTC unit, which will re-launch the 60-year-old antacid brand. “The acquisition is consistent with your long-term strategy, which includes growing our consumer healthcare offering as part of a broader diversification strategy,” said Anne Whittaker, president for North America Pharmaceuticals at Sanofi, in a statement. “Chattem has a proven track record of successful acquisitions and integrations and the addition of Rolaids, an enduring brand with a deep heritage, further diversifies the company's portfolio.” 

Elsevier has purchased the private database firm Aureus Sciences, founded in 2002. The firm's tools help researchers home in on drug repurposing potential as well as promising compounds. The publisher also announced that its portfolio now includes the Journal of Cell Therapy, the journal of the International Society for Cellular Therapy. The society said in a statement Monday that it chose the publisher because of its “unsurpassed reach into the global medical community, top class publishing services and significant experience in the field.”
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.

Study says statins not enough for diabetic hearts

Researchers using an experimental test have discovered that the 50% of surveyed diabetics may also have undetected heart muscle damage.